Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Virtual Congress 2020

AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer

HER new potential: New advances in HER2+ breast cancer treatment

Date

22 Sep 2020

Session

AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer

Presenters

Erika Hamilton

Authors

E.P. Hamilton

Author affiliations

  • Drug Development Unit, Sarah Cannon Research Institute-Cancer Centre, 37203 - Nashville/US

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

Welcome and introductions

Presenter: Eva Ciruelos

Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer

Resources:

Webcast

Closing remarks

Presenter: Eva Ciruelos

Session: AstraZeneca - HER tomorrow in HER2+ metastatic breast cancer

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.